Jane Griffiths is a non-executive director of Johnson Matthey Plc. She is also a member of the board of directors of TB Alliance, a not-for-profit organisation dedicated to the discovery, development and delivery of better, faster acting and affordable tuberculosis drugs that are available to those who need them.
She enjoyed a long career with Johnson & Johnson, during which she held executive roles in clinical research, international and strategic marketing, product management and operational management. In her last role before retiring in December 2019, Jane was Global Head of Acetelion, where she led the integration of the Swiss biotech business following its acquisition by Johnson & Johnson. Prior to that Jane had been Company Group Chair of Janssen EMEA, the group’s research based pharmaceutical arm. During her time with Johnson & Johnson, Jane led its Corporate Citizen Trust in EMEA and sponsored its Women’s Leadership Initiative. Jane was also sponsor of Janssen’s Global Pharmaceuticals Sustainability Council.
Jane is a past Chair of the European Federation of Pharmaceutical Industries and Associations, past Chairwoman of the PhRMA Europe Committee and former member of the Corporate Advisory Board of the UK Government backed ‘Your Life’ campaign, aimed at encouraging more people to study STEM subjects.